menu search

L3harris secures $947m contract to improve b-52 self-defense

L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...

October 5, 2021, 11:52 am

L3harris secures $947m contract to improve b-52 self-defense

L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...

October 5, 2021, 11:52 am

L3harris secures $947m contract to improve b-52 self-defense

L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...

October 5, 2021, 11:52 am

L3harris secures $947m contract to improve b-52 self-defense

L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...

October 5, 2021, 11:52 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...

October 5, 2021, 4:31 am


Search within

Pages Search Results: